Karl Härfstrand
Oprichter bij Härfstrand Consulting AG
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Karl Härfstrand
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Pharmacia & Upjohn, Inc.
35
| Extinct | Pharmaceuticals: Major | 35 |
| Public Company | Biotechnology | 21 | |
Pharmacia AB
19
| Extinct | Pharmaceuticals: Major | 19 |
| Subsidiary | Pharmaceuticals: Major | 19 | |
Karolinska Institutet
19
| College/University | Other Consumer Services | 19 |
17
| Public Company | Pharmaceuticals: Generic | 17 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Pharmacia, Inc.
11
| Extinct | 11 | |
| Public Company | Financial Conglomerates | 10 | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
| Public Company | Packaged Software | 9 | |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands.
2
| Extinct | Pharmaceuticals: Major | 2 |
| Subsidiary | Pharmaceuticals: Major | 2 | |
| Subsidiary | Chemicals: Agricultural | 2 | |
Humabs BioMed SA
 Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Karl Härfstrand via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| CARDINAL HEALTH, INC. | Medical Distributors | Director/Board Member Director/Board Member | |
| CELGENE | Biotechnology | Director/Board Member Director/Board Member | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Virginia | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HOIST FINANCE AB | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Director/Board Member | |
| RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
| New York University | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Private Equity Investor Chairman Chief Executive Officer Chief Executive Officer Director of Finance/CFO | |
| ABLYNX | Biotechnology | Chairman Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
| NAVAMEDIC ASA | Medical Distributors | Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| Pharmacia Ophthalmics AB | Chairman Corporate Officer/Principal Corporate Officer/Principal | ||
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Corporate Officer/Principal | |
| BIOARCTIC AB | Pharmaceuticals: Major | Chairman Founder Director/Board Member | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Kabi Pharmacia | Corporate Officer/Principal President | ||
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
TFS Trial Form Support International AB
 TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| CANTARGIA AB | Pharmaceuticals: Major | Chairman Chairman | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Director/Board Member President General Counsel Chief Tech/Sci/R&D Officer | |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| Novartis Ophthalmics AG | Chief Executive Officer Corporate Officer/Principal | ||
| Aprea Personal AB | Director/Board Member Chairman Chairman | ||
Cobra Biologics Holding AB
 Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
| FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Zweden | 23 |
| Verenigde Staten | 17 |
| Denemarken | 5 |
| Duitsland | 3 |
| Ierland | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Distribution Services | 4 |
| Finance | 2 |
Operationeel
| Director/Board Member | 539 |
| Corporate Officer/Principal | 252 |
| Chairman | 164 |
| Independent Dir/Board Member | 130 |
| Chief Executive Officer | 110 |
Sterkste connecties
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Ulf Rosén | 45 |
| Göran Albert Ando | 44 |
| Wenche Nelly A. Rolfsen Sandsborg | 36 |
| Johan Rutger Christenson | 35 |
| Carl-Johan Spak | 35 |
| Bo Jesper Hansen | 34 |
| Helen Kim | 33 |
| Fred Hassan | 29 |
| Mark Corrigan | 29 |
| Gunilla Öhman | 29 |
| James Sapirstein | 26 |
| Laura González Molero | 25 |
| Daniel Welch | 24 |
| Sven Arne Andréasson | 24 |
- Beurs
- Insiders
- Karl Härfstrand
- Bedrijfsconnecties
